Recursion Pharmaceuticals RXRX Balance Sheet

Income Statement

Quarter End	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	610.35M	734.32M	672.52M	611.53M	701.29M	627.37M	666.7M	630.83M
Total Current Assets	534.72M	619.46M	546M	481.62M	569.81M	492.13M	431.02M	410.52M
Cash and Equivalents	285.12M	507.89M	453.88M	454.65M	549.91M	473.15M	405.87M	387.32M
Total Non-Current Assets	140.35M	185.57M	208.03M	215.69M	219.67M	225.25M	325.45M	306.55M
Total Liabilities	67.41M	240.75M	234.94M	223.5M	215.48M	197.19M	197.74M	192.86M
Total Current Liabilities	46.66M	85.71M	96.65M	83.04M	100.27M	92.15M	113.96M	94.12M
Total Non-Current Liabilities	21.38M	155.66M	138.87M	141.02M	115.75M	106.22M	84.93M	99.87M
Common Equity	2k	2k	2k	2k	2k	2k	2k	2k
Retained Earnings	-400.08M	-456.06M	-521.62M	-582.06M	-639.56M	-704.88M	-781.61M	-874.63M

Year End December 30 2023	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	101.43M	298.59M	610.35M	701.29M	653.7M
Total Current Assets	76.4M	269.48M	534.72M	569.81M	438.14M
Cash and Equivalents	69.88M	262.13M	285.12M	549.91M	391.57M
Total Non-Current Assets	-124.27M	-206.29M	542.94M	485.81M	463.44M
Total Liabilities	24.59M	56.56M	67.41M	215.48M	190.26M
Total Current Liabilities	6.68M	23.1M	46.66M	100.27M	93.17M
Total Non-Current Liabilities	30.32M	44.88M	21.38M	115.75M	98.19M
Total Equity	-124.27M	-206.29M	542.94M	485.81M	463.44M
Common Equity	2.33M	7.31M	2k	2k	2k
Retained Earnings	0	0	-400.08M	-639.56M	-967.62M